Top

Published in:

Open Access 20-02-2024 | Radiotherapy | REVIEW

Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway

Authors: Marion Florimond, Lucas T. Duong, Elodie Lours, Jean-Jacques Brau, François C. Ferré, Isabelle Fouilloux, Tchilalo Boukpessi

Published in: Current Oncology Reports | Issue 3/2024

Abstract

Purpose of Review

This work consists in a literature review on the current state of knowledge regarding the oral management of patients with a history of head and neck cancer (HNC), corroborated by clinical cases and illustrated by clear infographic summaries. It aims to provide healthcare professionals with a comprehensive overview of the oral health status of HCN patients.

Recent Findings

Head and neck cancers (HNCs) represent the seventh most common type of cancer worldwide, with over 660,000 annual new cases. Despite the significant negative impact of HNCs on oral health, patients often receive no or inappropriate oral care while the significant impact of oral pathologies on cancer prognosis is commonly underestimated.

Summary

This work (i) describes the oral cavity during and after HNC through the prism of care complexity and (ii) highlights several potential key factors that could worsen long-time patients’ prognosis and quality of life. By investigating the biological, microbiological, functional, and psychological dimensions of the interrelationships between HNCs and oral health, the authors explored the barriers and benefits of a targeted oral healthcare pathway. This article emphasizes the importance of multidisciplinary care and highlights the need for further research elucidating the intricate relationships between oral health and HNCs, particularly through the microbiota.

Guo K, Xiao W, Chen X, Zhao Z, Lin Y, Chen G. Epidemiological trends of head and neck cancer: a population-based study. BioMed Res Int. 2021;2021:1–14. https://doi.org/10.1155/2021/1738932.CrossRef

Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60–72. https://doi.org/10.1056/NEJMra1715715.CrossRefPubMed

Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. The Lancet. 2021;398:2289–99. https://doi.org/10.1016/S0140-6736(21)01550-6.CrossRef

Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H. Radiation-related damage to dentition. Lancet Oncol. 2006;7:326–35. https://doi.org/10.1016/S1470-2045(06)70658-1.CrossRefPubMed

Epstein JB, Thariat J, Bensadoun R-J, Barasch A, Murphy BA, Kolnick L, et al. Oral complications of cancer and cancer therapy. CA Cancer J Clin. 2012;62:400–22. https://doi.org/10.3322/caac.21157.CrossRefPubMed

Baudelet M, Van den Steen L, Tomassen P, Bonte K, Deron P, Huvenne W, et al. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy. Head Neck. 2019;41:3594–603. https://doi.org/10.1002/hed.25880.CrossRefPubMed

Zhang Y, Wang X, Li H, Ni C, Du Z, Yan F. Human oral microbiota and its modulation for oral health. Biomed Pharmacother. 2018;99:883–93. https://doi.org/10.1016/j.biopha.2018.01.146.CrossRefPubMed

Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJL, Marcenes W. Global burden of untreated caries: a systematic review and metaregression. J Dent Res. 2015;94:650–8. https://doi.org/10.1177/0022034515573272.CrossRefPubMed

World Health Organization. Sugar and dental caries 2017. https://www.who.int/news-room/fact-sheets/detail/sugars-and-dental-caries. Accessed 23 May 2023.

10.

World Health Organization. Global oral health status report 2022. https://www.who.int/team/noncommunicable-diseases/global-status-report-on-oral-health-2022. Accessed 23 May 2023.

11.

Peng X, Cheng L, You Y, Tang C, Ren B, Li Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022;14:14. https://doi.org/10.1038/s41368-022-00163-7.CrossRefPubMedPubMedCentral

12.

• Niazi SA, Bakhsh A. Association between endodontic infection, its treatment and systemic health: a narrative review. Med Kaunas Lith. 2022;58:931. https://doi.org/10.3390/medicina58070931. This review highlights the systemic impact of infections resulting from dental caries. It describes the potential role of dental-associated bacteremia and low-grade systemic inflammation in the development of cardiovascular disease, adverse pregnancy outcomes and metabolic dyscontrol in diabetes. It provides essential information on the links between oral health and systemic health.CrossRef

13.

Segura-Egea JJ, Martín-González J, Castellanos-Cosano L. Endodontic medicine: connections between apical periodontitis and systemic diseases. Int Endod J. 2015;48:933–51. https://doi.org/10.1111/iej.12507.CrossRefPubMed

14.

Guo A, Wide U, Arvidsson L, Eiben G, Hakeberg M. Dietary intake and meal patterns among young adults with high caries activity: a cross-sectional study. BMC Oral Health. 2022;22:1–9. https://doi.org/10.1186/s12903-022-02227-w.CrossRef

15.

Reis Ferreira M, Pasto A, Ng T, Patel V, Guerrero Urbano T, Sears C, et al. The microbiota and radiotherapy for head and neck cancer: what should clinical oncologists know? Cancer Treat Rev. 2022;109:102442. https://doi.org/10.1016/j.ctrv.2022.102442.CrossRefPubMed

16.

• Bruno JS, Al-Qadami GH, Laheij AMGA, Bossi P, Fregnani ER, Wardill HR. From pathogenesis to intervention: the importance of the microbiome in oral mucositis. Int J Mol Sci. 2023;24:8274. https://doi.org/10.3390/ijms24098274. This work explores the intricacies between the oral and gut microbiome and the development of oral mucositis (OM) associated with cancer therapy. Authors explore the emerging role of a patient’s microbial fingerprint in OM development and prediction. This is an interesting aspect of the links between oral health and cancer.CrossRefPubMedPubMedCentral

17.

Zhu X-X, Yang X-J, Chao Y-L, Zheng H-M, Sheng H-F, Liu H-Y, et al. The potential effect of oral microbiota in the prediction of mucositis during radiotherapy for nasopharyngeal carcinoma. EBioMedicine. 2017;18:23–31. https://doi.org/10.1016/j.ebiom.2017.02.002.CrossRefPubMedPubMedCentral

18.

Jiang R, Liu Y, Zhang H, Chen Y, Liu T, Zeng J, et al. Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma. Front Cell Infect Microbiol 2022;12. https://doi.org/10.3389/fcimb.2022.1070322.

19.

Jasmer KJ, Gilman KE, Muñoz Forti K, Weisman GA, Limesand KH. Radiation-induced salivary gland dysfunction: mechanisms, therapeutics and future directions. J Clin Med. 2020;9:4095. https://doi.org/10.3390/jcm9124095.CrossRefPubMedPubMedCentral

20.

Dreizen S, Brown LR, Handler S, Levy BM. Radiation-induced xerostomia in cancer patients. Effect on salivary and serum electrolytes. Cancer 1976;38:273–8. https://doi.org/10.1002/1097-0142(197607)38:1<273::aid-cncr2820380141>3.0.co;2-8.

21.

• Muñoz MA, Garín-Correa C, González-Arriagada W, Quintela Davila X, Häberle P, Bedran-Russo A, et al. The adverse effects of radiotherapy on the structure of dental hard tissues and longevity of dental restoration. Int J Radiat Biol. 2020;96:910–8. https://doi.org/10.1080/09553002.2020.1741718. This in vitro study explores: (i) the structural alterations of enamel and dentin; and (ii) the influence on the bonding strength stability after ionizing radiation from 0 to 70Gy. It provides essential biological data to offer targeted oral treatment to HNC patients.CrossRefPubMed

22.

•• Douchy L, Gauthier R, Abouelleil-Sayed H, Colon P, Grosgogeat B, Bosco J. The effect of therapeutic radiation on dental enamel and dentin: a systematic review. Dent Mater. 2022;38:e181-201. https://doi.org/10.1016/j.dental.2022.04.014. This systematic review explores the tissular changes induced by radiotherapy in teeth. It provides essential biological data to offer targeted oral treatment to HNC patients.CrossRefPubMed

23.

Martini GR, Bortoluzzi EA, Minamisako MC, Bordignon NCT, Rodrigues PM, Gondak R. Impact of radiotherapy on the morphological and compositional structure of intra-radicular dentin. Braz Dent J n.d.;34:45–51. https://doi.org/10.1590/0103-6440202305101.

24.

Eggmann F, Hwang JD, Ayub JM, Mante FK. Impact of irradiation on the adhesive performance of resin-based dental biomaterials: a systematic review of laboratory studies. Materials. 2023;16:2580. https://doi.org/10.3390/ma16072580.CrossRefPubMedPubMedCentralADS

25.

Poyton HG. The effects of radiation on teeth. Oral Surg Oral Med Oral Pathol. 1968;26:639–46. https://doi.org/10.1016/0030-4220(68)90430-1.CrossRefPubMed

26.

Palmier NR, Ribeiro ACP, Fonsêca JM, Salvajoli JV, Vargas PA, Lopes MA, et al. Radiation-related caries assessment through the International Caries Detection and Assessment System and the Post-Radiation Dental Index. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:542–7. https://doi.org/10.1016/j.oooo.2017.08.019.CrossRefPubMed

27.

Hajishengallis G. Interconnection of periodontal disease and comorbidities: evidence, mechanisms, and implications. Periodontol. 2000;2022(89):9–18. https://doi.org/10.1111/prd.12430.CrossRef

28.

Kalhan AC, Wong ML, Allen F, Gao X. Periodontal disease and systemic health: an update for medical practitioners. Ann Acad Med Singapore. 2022;51:567–74. https://doi.org/10.47102/annals-acadmedsg.2021503.CrossRefPubMed

29.

Sedghi LM, Bacino M, Kapila YL. Periodontal disease: the good, the bad, and the unknown. Front Cell Infect Microbiol. 2021;11:766944. https://doi.org/10.3389/fcimb.2021.766944.CrossRefPubMedPubMedCentral

30.

Bahig H, Fuller CD, Mitra A, Yoshida-Court K, Solley T, Ping Ng S, et al. Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer. Clin Transl Radiat Oncol. 2021;26:98–103. https://doi.org/10.1016/j.ctro.2020.11.007.CrossRefPubMed

31.

Hoare A, Wang H, Meethil A, Abusleme L, Hong B-Y, Moutsopoulos NM, et al. A cross-species interaction with a symbiotic commensal enables cell-density-dependent growth and in vivo virulence of an oral pathogen. ISME J. 2021;15:1490–504. https://doi.org/10.1038/s41396-020-00865-y.CrossRefPubMed

32.

Xanthinaki A, Nicolatou-Galitis O, Athanassiadou P, Gonidi M, Kouloulias V, Sotiropoulou-Lontou A, et al. Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report. Support Care Cancer. 2008;16:1025–33. https://doi.org/10.1007/s00520-007-0379-8.CrossRefPubMed

33.

Bossi P, Bergamini C, Miceli R, Cova A, Orlandi E, Resteghini C, et al. Salivary cytokine levels and oral mucositis in head and neck cancer patients treated with chemotherapy and radiation therapy. Int J Radiat Oncol. 2016;96:959–66. https://doi.org/10.1016/j.ijrobp.2016.08.047.CrossRef

34.

Liu X, Li H. A systematic review and meta-analysis on multiple cytokine gene polymorphisms in the pathogenesis of periodontitis. Front Immunol. 2021;12:713198. https://doi.org/10.3389/fimmu.2021.713198.CrossRefPubMed

35.

Takenaka Y, Cho H, Yamamoto M, Nakahara S, Yamamoto Y, Inohara H. Incidence and predictors of febrile neutropenia during chemotherapy in patients with head and neck cancer. Support Care Cancer. 2013;21:2861–8. https://doi.org/10.1007/s00520-013-1873-9.CrossRefPubMed

36.

Kitaya S, Kakuta R, Kanamori H, Ohkoshi A, Ishii R, Nomura K, et al. Clinical and epidemiological characteristics of bloodstream infections in head and neck cancer patients: a decadal observational study. J Clin Med. 2022;11:4820. https://doi.org/10.3390/jcm11164820.CrossRefPubMedPubMedCentral

37.

Xu J, Yang G, An W, Wang W, Li F, Meng Y, et al. Correlations between the severity of radiation-induced oral mucositis and salivary epidermal growth factor as well as inflammatory cytokines in patients with head and neck cancer. Head Neck. 2023;45:1122–9. https://doi.org/10.1002/hed.27313.CrossRefPubMed

38.

Vosselman N, Alberga J, Witjes MHJ, Raghoebar GM, Reintsema H, Vissink A, et al. Prosthodontic rehabilitation of head and neck cancer patients—challenges and new developments. Oral Dis. 2021;27:64–72. https://doi.org/10.1111/odi.13374.CrossRefPubMed

39.

• Wiedenmann F, Liebermann A, Probst F, Troeltzsch M, Balermpas P, Guckenberger M, et al. A pattern of care analysis: prosthetic rehabilitation of head and neck cancer patients after radiotherapy. Clin Implant Dent Relat Res. 2020;22:333–41. https://doi.org/10.1111/cid.12912. This study shows that when considering prosthetic oral rehabilitation, the practitioner’s area of expertise and working environment affect the therapeutic decision, which is known to have an impact on quality of life. It explores the under-researched issue of the oral healthcare pathway for HNC patients, focusing on the dimension of prosthetic rehabilitation.CrossRefPubMed

40.

Zierden K, Wöstmann J, Wöstmann B, Rehmann P. Clinical performance of different types of dental prosthesis in patients with head and neck tumors—a retrospective cohort study. Clin Oral Investig. 2022;26:7121–33. https://doi.org/10.1007/s00784-022-04673-w.CrossRefPubMedPubMedCentral

41.

• Silvestri F, Saliba-Serre B, Graillon N, Fakhry N, Ruquet M, Maille G. Quality of life in irradiated patients with head and neck cancer: a preliminary study about the impact of prosthetic rehabilitation. J Clin Exp Dent. 2021;13:e906–12. https://doi.org/10.4317/jced.58209. This preliminary study involves 28 HNC patients who had undergone radiotherapy and explores the impact of prosthetic rehabilitation on quality of life. It provides data that shows the need to investigate this topic, with functional, aesthetic and social implications.CrossRefPubMedPubMedCentral

42.

• Silvestri F, Saliba-Serre B, Ruquet M, Graillon N, Fakhry N, Mourad A, et al. Quality of life of patients irradiated for head and neck cancer and impact of rehabilitation with a removable dental prosthetic: 1-year follow-up study. J Clin Exp Dent. 2022;14:e221–8. https://doi.org/10.4317/jced.59315. This study shows the impact of prosthetic rehabilitation on HNC patients, particularly with regard to the psychosocial aspect.CrossRefPubMedPubMedCentral

43.

Inamochi Y, Fueki K, Matsuyama Y, Yoshida-Kohno E, Fujiwara T, Wakabayashi N. Does oral dryness influence pressure pain sensitivity in the oral mucosa of removable denture wearers? Clin Oral Investig. 2020;24:2603–9. https://doi.org/10.1007/s00784-019-03118-1.CrossRefPubMed

44.

Tanaka A, Kellesarian SV, Arany S. Xerostomia and patients’ satisfaction with removable denture performance: systematic review. Quintessence Int Berl Ger. 1985;2021(52):46–55. https://doi.org/10.3290/j.qi.a45427.CrossRef

45.

Tarapan S, Matangkasombut O, Trachootham D, Sattabanasuk V, Talungchit S, Paemuang W, et al. Oral Candida colonization in xerostomic postradiotherapy head and neck cancer patients. Oral Dis. 2019;25:1798–808. https://doi.org/10.1111/odi.13151.CrossRefPubMed

46.

Hori Y, Kondo Y, Nodai T, Masaki C, Ono K, Hosokawa R. Xerostomia aggravates ligation-induced peri-implantitis: a preclinical in vivo study. Clin Oral Implants Res. 2021;32:581–9. https://doi.org/10.1111/clr.13727.CrossRefPubMed

47.

Sahrmann P, Gilli F, Wiedemeier DB, Attin T, Schmidlin PR, Karygianni L. The microbiome of peri-implantitis: a systematic review and meta-analysis. Microorganisms. 2020;8:661. https://doi.org/10.3390/microorganisms8050661.CrossRefPubMedPubMedCentral

48.

Neckel N, Wagendorf P, Sachse C, Stromberger C, Vach K, Heiland M, et al. Influence of implant-specific radiation doses on peri-implant hard and soft tissue: an observational pilot study. Clin Oral Implants Res. 2021;32:249–61. https://doi.org/10.1111/clr.13696.CrossRefPubMed

49.

Howe M-S, Keys W, Richards D. Long-term (10-year) dental implant survival: a systematic review and sensitivity meta-analysis. J Dent. 2019;84:9–21. https://doi.org/10.1016/j.jdent.2019.03.008.CrossRefPubMed

50.

Chronopoulos A, Zarra T, Ehrenfeld M, Otto S. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J. 2020;68:22–30. https://doi.org/10.1111/idj.12318.CrossRefPubMedCentral

51.

• Frankart AJ, Frankart MJ, Cervenka B, Tang AL, Krishnan DG, Takiar V. Osteoradionecrosis: exposing the evidence not the bone. Int J Radiat Oncol Biol Phys. 2021;109:1206–18. https://doi.org/10.1016/j.ijrobp.2020.12.043. This review provides an overview of current knowledge regarding osteoradionecrosis. It highlights the lack of guidelines for assessment and management.CrossRefPubMed

52.

Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol Stockh Swed. 2019;58:1373–7. https://doi.org/10.1080/0284186X.2019.1643037.CrossRef

53.

Elting LS, Chang Y-C. Costs of oral complications of cancer therapies: estimates and a blueprint for future study. J Natl Cancer Inst Monogr. 2019;2019:lgz010. https://doi.org/10.1093/jncimonographs/lgz010.CrossRefPubMed

54.

Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin. 2022;72:57–77. https://doi.org/10.3322/caac.21704.CrossRefPubMed

55.

Rodrigues-Oliveira L, Kowalski LP, Santos M, Marta GN, Bensadoun R-J, Martins MD, et al. Direct costs associated with the management of mucositis: a systematic review. Oral Oncol. 2021;118:105296. https://doi.org/10.1016/j.oraloncology.2021.105296.CrossRefPubMed

56.

Leerahakan P, Matangkasombut O, Tarapan S, Lam-ubol A. Biofilm formation of Candida isolates from xerostomic post-radiotherapy head and neck cancer patients. Arch Oral Biol. 2022;142:105495. https://doi.org/10.1016/j.archoralbio.2022.105495.CrossRefPubMed

57.

de Freitas EM, Nobre SAM, Pires MB de O, Faria RVJ, Batista AUD, Bonan PRF. Oral Candida species in head and neck cancer patients treated by radiotherapy. Auris Nasus Larynx 2013;40:400–4. https://doi.org/10.1016/j.anl.2012.11.011.

58.

Gissi DB, Asioli S, Gabusi A. Two unusual cases of oral lichen planus arising after oral squamous cell carcinoma: can oral cancer trigger autoimmunity? Int J Surg Pathol. 2017;25:443–8. https://doi.org/10.1177/1066896917699070.CrossRefPubMed

59.

Wang Y-N, Chen HC, Wang B, Fang H. Oral and esophageal lichen planus following radiotherapy of nasopharyngeal carcinoma. Acta Derm Venereol. 2011;91:94–5. https://doi.org/10.2340/00015555-0967.CrossRefPubMed

60.

Economopoulou P, Nicolatou-Galitis O, Kotsantis I, Psyrri A. Nivolumab-related lichen planus of the lip in a patient with head and neck cancer. Oral Oncol. 2020;104:104623. https://doi.org/10.1016/j.oraloncology.2020.104623.CrossRefPubMed

61.

Botticelli A, Cirillo A, Strigari L, Valentini F, Cerbelli B, Scagnoli S, et al. Anti-PD-1 and anti-PD-L1 in head and neck cancer: a network meta-analysis. Front Immunol. 2021;12:705096. https://doi.org/10.3389/fimmu.2021.705096.CrossRefPubMedPubMedCentral

62.

•• Dorobisz K, Dorobisz T, Zatoński T. The microbiome’s influence on head and neck cancers. Curr Oncol Rep. 2023;25:163–71. https://doi.org/10.1007/s11912-022-01352-7. This review reports on the current state of knowledge concerning the impact of the microbiome on the pathogenesis, evolution and treatment of HNCs. It provides essential data that must be correlated with existing knowledge of bacteria-related oral pathologies.CrossRefPubMedPubMedCentral

63.

Abranches J, Zeng L, Kajfasz J, Palmer S, Chakraborty B, Wen Z, et al. Biology of oral streptococci. Microbiol Spectr 2018;6:. https://doi.org/10.1128/microbiolspec.GPP3-0042-2018.

64.

Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16:745–59. https://doi.org/10.1038/s41579-018-0089-x.CrossRefPubMedPubMedCentral

65.

Stasiewicz M, Karpiński TM. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 2022;86:633–42. https://doi.org/10.1016/j.semcancer.2021.11.002.CrossRefPubMed

66.

Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6:22613–23. https://doi.org/10.18632/oncotarget.4209.CrossRefPubMed

67.

Sun J, Tang Q, Yu S, Xie M, Xie Y, Chen G, et al. Role of the oral microbiota in cancer evolution and progression. Cancer Med. 2020;9:6306–21. https://doi.org/10.1002/cam4.3206.CrossRefPubMedPubMedCentral

68.

Woo BH, Kim DJ, Choi JI, Kim SJ, Park BS, Song JM, et al. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential. Oncotarget. 2017;8:46981–92. https://doi.org/10.18632/oncotarget.16550.CrossRefPubMedPubMedCentral

69.

Vadovics M, Ho J, Igaz N, Alföldi R, Rakk D, Veres É, et al. Candida albicans enhances the progression of oral squamous cell carcinoma in vitro and in vivo. mBio. 2021;13:e0314421. https://doi.org/10.1128/mBio.03144-21.CrossRefPubMed

70.

Mohamad I, Abu Hejleh T, Abdelqader S, Wahbeh L, Taqash A, Almousa A, et al. Re-irradiation for recurrent head and neck cancer: freedom from cancer recurrence rate. J Clin Med. 2023;12:2979. https://doi.org/10.3390/jcm12082979.CrossRefPubMedPubMedCentral

71.

Katsura K, Sasai K, Sato K, Saito M, Hoshina H, Hayashi T. Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:731–8. https://doi.org/10.1016/j.tripleo.2007.10.011.CrossRefPubMed

72.

Kufta K, Forman M, Swisher-McClure S, Sollecito TP, Panchal N. Pre-radiation dental considerations and management for head and neck cancer patients. Oral Oncol. 2018;76:42–51. https://doi.org/10.1016/j.oraloncology.2017.11.023.CrossRefPubMed

73.

•• Sabancı A, Karasu B, Sabancı HI, Kuku İ, Kırmızıgul OA. Impact of periodontal status on the oral mucositis in patients receiving high-dose chemotherapy. Clin Oral Investig. 2022;26:6341–6. https://doi.org/10.1007/s00784-022-04588-6. This study is one of the few to investigate the impact of oral pathologies on cancer, focusing on the interrelationships between periodontal disease and chemo-induced oral mucositis. Although it focuses on haematological cancers, it shows the importance of oral management in the prognosis of cancers.CrossRefPubMed

74.

Hong B-Y, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7:1–18. https://doi.org/10.1186/s40168-019-0679-5.CrossRef

75.

Jin Y-N, Xia T-L, Mai D-M, Yao J-J, Jiang C, He W-Z, et al. The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study. BMC Cancer. 2022;22:505. https://doi.org/10.1186/s12885-022-09562-9.CrossRefPubMedPubMedCentral

76.

de Groot RJ, Wetzels J-W, Merkx MAW, Rosenberg AJWP, de Haan AFJ, van der Bilt A, et al. Masticatory function and related factors after oral oncological treatment: a 5-year prospective study. Head Neck. 2019;41:216–24. https://doi.org/10.1002/hed.25445.CrossRefPubMed

77.

• de Groot RJ, Merkx MAW, Hamann MNS, Brand HS, de Haan AFJ, Rosenberg AJWP, et al. Tongue function and its influence on masticatory performance in patients treated for oral cancer: a five-year prospective study. Support Care Cancer 2020;28:1491–501. https://doi.org/10.1007/s00520-019-04913-y. This study is one of the few to explore the specifics of masticatory function in HNC patients. It provides data that need to be completed in order to improve the management of HNC patients.

78.

• Vermaire JA, Weinberg FM, Raaijmakers CPJ, Verdonck-de Leeuw IM, Terhaard CHJ, Speksnijder CM. Reliability of the mixing ability test testing masticatory performance in patients with head and neck cancer and healthy controls. J Oral Rehabil. 2020;47:961–6. https://doi.org/10.1111/joor.13029. This study is one of the few to explore the specifics of masticatory function in HNC patients. It provides data that need to be further developed in order to improve the management of HNC patients.

79.

Pai P-C, Chuang C-C, Tseng C-K, Tsang N-M, Chang K-P, Yen T-C, et al. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation. Int J Radiat Oncol Biol Phys. 2012;83:e93-100. https://doi.org/10.1016/j.ijrobp.2011.11.071.CrossRefPubMed

80.

Zeng Q, Shen L-J, Guo X, Guo X-M, Qian C-N, Wu P-H. Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma. BMC Cancer. 2016;16:169. https://doi.org/10.1186/s12885-016-2214-4.CrossRefPubMedPubMedCentral

81.

Oei RW, Ye L, Huang J, Kong F, Xu T, Shen C, et al. Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study. OncoTargets Ther. 2018;11:4857–68. https://doi.org/10.2147/OTT.S165133.CrossRef

82.

Zimmaro LA, Sephton SE, Siwik CJ, Phillips KM, Rebholz WN, Kraemer HC, et al. Depressive symptoms predict head and neck cancer survival: examining plausible behavioral and biological pathways. Cancer. 2018;124:1053–60. https://doi.org/10.1002/cncr.31109.CrossRefPubMed

83.

Wu Y-S, Lin P-Y, Chien C-Y, Fang F-M, Chiu N-M, Hung C-F, et al. Anxiety and depression in patients with head and neck cancer: 6-month follow-up study. Neuropsychiatr Dis Treat. 2016;12:1029–36. https://doi.org/10.2147/NDT.S103203.CrossRefPubMedPubMedCentral

84.

Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233:780–6. https://doi.org/10.1038/s41415-022-5166-x.CrossRefPubMedPubMedCentral

85.

Gonçalves LMN, Palma-Dibb RG, Paula-Silva FWG, de Oliveira HF, Nelson-Filho P, da Silva LAB, et al. Radiation therapy alters microhardness and microstructure of enamel and dentin of permanent human teeth. J Dent. 2014;42:986–92. https://doi.org/10.1016/j.jdent.2014.05.011.CrossRefPubMed

Title: Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway
Authors: Marion Florimond
Lucas T. Duong
Elodie Lours
Jean-Jacques Brau
François C. Ferré
Isabelle Fouilloux
Tchilalo Boukpessi
Publication date: 20-02-2024
Publisher: Springer US
Keywords: Radiotherapy
Gingival Diseases
Published in: Current Oncology Reports / Issue 3/2024
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI: https://doi.org/10.1007/s11912-024-01507-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2024

Establishing an Integrative Oncology Service: Essential Aspects of Program Development

Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer

Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies

Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade

The Dairy and Cancer Controversy: Milking the Evidence

Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer